期刊
JOURNAL OF NEUROTRAUMA
卷 29, 期 3, 页码 589-599出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/neu.2011.2059
关键词
fibronectin; inflammation; mechanical allodynia; serotonin; thermal hyperalgesia
资金
- Cleveland Clinic Foundation
- National Institutes of Health/National Institute for Neurological Diseases and Stroke (NIH/NINDS) [NS069765, NS25713]
Chronic pain following spinal cord injury (SCI) is a highly prevalent clinical condition that is difficult to treat. Using both von Frey filaments and radiant infrared heat to assess mechanical allodynia and thermal hyperalgesia, respectively, we have demonstrated that a one-time injection of fibronectin (50 mu g/mL) into the spinal dorsal column (1 mu L/min each injection for a total of 5 mu L) immediately after SCI inhibits the development of mechanical allodynia (but not thermal hyperalgesia) over an 8-month observation period following spinal cord dorsal column crush (DCC). DCC will only induce mechanical Allodynia, but not thermal hyperalgesia or overt motor deficits. By applying various fibronectin fragments as well as competitive inhibitors, these effects were shown to be dependent on the connecting segment-1 (CS-1) motif of fibronectin. Furthermore, we found that acute fibronectin treatment diminished inflammation and blood-spinal cord barrier permeability, which in turn leads to enhanced fiber sparing and sprouting. In particular, the reduction of serotonin (5-HT) in the superficial dorsal horn, an important descending brainstem system in the modulation of pain, was blocked with fibronectin treatment. We conclude that treatment of SCI with fibronectin preserves sensory regulation and prevents the development of chronic allodynia, providing a potential therapeutic intervention to treat chronic pain following SCI.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据